Lung Cancer News

Patients with non-small cell lung cancer who had stopped smoking before diagnosis had higher rates of survival after diagnosis, results of a retrospective cohort study showed.

More than three-fourths of newspaper articles on lung cancer screening published from 2010 to 2022 had a positive sentiment, according to study results published in American Journal of Roentgenology.

Cancers with high vs. low tumor mutational burden appeared significantly associated with improved clinical outcomes among patients treated with immune checkpoint inhibitors, according to data published in JAMA Network Open.

Use of a nurse navigator led to the discovery of more patients eligible for low-dose CT lung cancer screening and more screenings ordered, according to results published in Annals of Family Medicine.

Pembrolizumab demonstrated clinical activity among patients with diffuse malignant peritoneal mesothelioma, regardless of PD-L1 status or histology, according to data published in JAMA Network Open.

Patients with resectable non-small cell lung cancer who received perioperative durvalumab with neoadjuvant chemotherapy had significantly longer EFS and higher pathologic complete response rates than those who received chemotherapy alone.

High incidence of lung cancer paired with stable lung cancer-related mortality rates when low-dose CT screening was introduced suggests overdiagnosis, specifically in women, according to study results published in CHEST.

Social determinants of health and lack of access to specialty cancer care led to survival disparities among patients with malignant pleural mesothelioma, results of a retrospective study showed.

Overall treatment outcomes among patients with extensive-stage small cell lung cancer who received first-line chemoimmunotherapy appeared comparable to those reported in pivotal clinical trials, according to study results.

Patients with limited-stage small cell lung cancer who received higher-dose, once-daily radiotherapy achieved outcomes comparable to those who received the standard lower-dose, once-daily regimen, according to phase 3 study results.